47.74.Z - Retail sale of medical and orthopedic products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
86.10.Z - Hospital activities
86.21.Z - General medical practice
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | 0,9 | 0,7 | -13,3 |
EBITDA | -0,3 | 0,9 | 0,8 | -14,4 |
Short time liabilities | 1,1 | 0,7 | 0,4 | -49,6 |
Equity capital | -0,2 | 0,6 | 1,3 | 109,3 |
Operating profit (EBIT) | -0,3 | 0,9 | 0,7 | -13,1 |
Assets | 0,9 | 1,4 | 1,7 | 22,6 |
Net profit (loss) | -0,3 | 0,8 | 0,7 | -18,9 |
Cash | 0,1 | 0,2 | 0,4 | 112,9 |
Net income from sale | 1,4 | 3,2 | 3,7 | 13,6 |
Liabilities and provisions for liabilities | 1,1 | 0,7 | 0,4 | -49,6 |
Working assets | 0,8 | 1,3 | 1,6 | 23,9 |
Depreciation | 0 | 0 | 0 | -68,4 |
% | % | % | p.p. | |
Profitability of capital | 160,6 | 134,8 | 52,2 | -82,6 |
Equity capital to total assets | -25,3 | 45,4 | 77,6 | 32,2 |
Gross profit margin | -24,6 | 26,7 | 20,4 | -6,3 |
EBITDA Margin | -24,2 | 27,3 | 20,6 | -6,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 277 | 85 | 38 | -47 |
Current financial liquidity indicator | 0.7475618124008179 | 1.7693763971328735 | 4.347752094268799 | 2,5 |
Net dept to EBITDA | 0.29792338609695435 | -0.21063947677612305 | -0.5235772728919983 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane